文献速递膀胱癌与上尿路尿路上皮癌

输尿管镜治疗上尿路尿路上皮癌的并发症

Complications Associated With Ureteroscopic Management of Upper Tract Urothelial Carcinoma.
PubMed 文献 · Urology · 2020-10-06

该研究汇总38篇文献(7项前瞻性、31项回顾性,超过1100例患者),分析低级别上尿路尿路上皮癌内镜治疗的安全性数据。输尿管狭窄是最常见并发症(26/38项研究报告,发生率0-27%),其发生与手术次数和治疗方式相关。严重及致死性并发症罕见,多数并发症轻微,支持在合适选择的患者中输尿管镜治疗的安全性。

要点

  • 输尿管狭窄是输尿管镜治疗上尿路尿路上皮癌最常见并发症,发生率0-27%。
  • 输尿管狭窄发生与手术次数和治疗方式相关。
  • 严重及致死性并发症罕见,多数并发症轻微。

核心结论

  • 输尿管狭窄是内镜治疗上尿路尿路上皮癌最常见的并发症,但多数病例可成功处理。
  • 多数并发症为轻微,严重和致死性并发症罕见。
  • 结果支持在适当选择的患者中输尿管镜治疗上尿路尿路上皮癌的安全性。

研究设计与样本

  • 检索Ovid Medline和Ovid Medline Daily(以Embase为二次检索),涵盖1946-2018年文献。
  • 纳入38篇出版物(7项前瞻性、31项回顾性研究),代表超过1100例患者。
  • 排除诊断性研究、病例研究和综述。

主要发现

  • 输尿管狭窄是最常报告的并发症(26/38项研究;发生率0-27%)。
  • 输尿管狭窄发生率与手术次数和治疗方式相关。
  • 出血、感染和发热在辅助治疗(BCG或丝裂霉素)时最常见。
  • 严重和致死性并发症罕见。

关键数值与推荐

  • 输尿管狭窄发生率0-27%(26/38项研究报告)。
  • 辅助治疗(BCG或丝裂霉素)时出血、感染和发热最常见。

临床怎么用

  • 对于低级别上尿路尿路上皮癌患者,输尿管镜管理是安全的选择,需注意输尿管狭窄风险。
  • 输尿管狭窄风险与手术次数和治疗方式相关,应优化治疗策略。
  • 辅助治疗(BCG或丝裂霉素)时需关注出血、感染和发热。

局限性

  • 需要更多前瞻性研究。
  • 纳入研究以回顾性为主(31/38项)。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: To compile and examine safety data from clinical studies of endoscopic management of patients with low-grade upper tract urothelial carcinoma (UTUC) to identify rates and factors associated with reported complications. METHODS: Ovid Medline and Ovid Medline Daily (with Embase as secondary search) including citations from 1946-2018 were queried using the following terms: ureteroscopy, ureter, catheter, endoscopy, complication, adverse events, morbidity, ablation, laser, upper tract urothelial carcinoma, ureteral stricture, ureteral stenosis, and ureteral injury. Abstracts were reviewed for relevance; diagnostic studies, case studies, and reviews were excluded. RESULTS: Thirty-eight publications (7 prospective, 31 retrospective) representing >1100 patients were identified. Ureteral stricture was the most frequently reported complication (studies; rates) (26/38; 0-27%), with incidence associated with number of procedures and treatment method. Bleeding, infection, and fever were most common with adjuvant treatment (BCG or mitomycin). Serious and fatal complications were rare. CONCLUSIONS: Ureteral stricture is the most frequent complication of endoscopic UTUC management but can be managed successfully in most cases. Most complications were minor. Although additional prospective studies are needed, these results support the safety of ureteroscopic management of UTUC in appropriately selected patients.

来源:Urology,查看原文。版权归原作者所有。

引用

  1. Linehan J, Schoenberg M, Seltzer E, et al. Complications Associated With Ureteroscopic Management of Upper Tract Urothelial Carcinoma. Urology. 2020. PMID: 33031842. doi:10.1016/j.urology.2020.09.036

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。